Schedule 13G ownership disclosure

CARDIOL THERAPEUTICS INC

Class A Common Shares · CUSIP: 14161Y200

Event date: 2025-10-17

Filing-level shares
5,130,122.00
Percent of class
5.2%
  • Tejara Capital Ltd

    Shares: 5,130,122.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001879713-25-000002
Form type
SCHEDULE 13G
Filer
Cardiol Therapeutics Inc.
CIK
CIK 1702123
Filed
Oct 23, 2025
Reporting period
Oct 17, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub